WOLVERINE ASSET MANAGEMENT LLC - INOTEK PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2020$7,298,000
-10.7%
7,500,0000.0%0.11%
+11.6%
Q4 2019$8,171,000
+9.8%
7,500,0000.0%0.10%
+1.1%
Q3 2019$7,439,000
-0.3%
7,500,0000.0%0.09%
-3.1%
Q2 2019$7,461,000
+622.3%
7,500,000
+650.0%
0.10%
+646.2%
Q4 2016$1,033,000
-24.2%
1,000,0000.0%0.01%
-35.0%
Q3 2016$1,362,0001,000,0000.02%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders